EMILY EWING: Open Payments
NPI 1386388858 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,406 in 93 payments from 28 companies in 2025. Trend: 2023 $588 · 2024 $628 · 2025 $2,406
Food & beverage: $2,406
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $410 |
| Neurelis, Inc. | 8 | $177 |
| SK Life Science, Inc. | 8 | $172 |
| Axsome Therapeutics, Inc. | 5 | $137 |
| Biogen, Inc. | 5 | $134 |
| Alkermes, Inc. | 1 | $129 |
| UCB, Inc. | 4 | $129 |
| Teva Pharmaceuticals USA, Inc. | 5 | $129 |
| Novo Nordisk Inc | 1 | $125 |
| TG Therapeutics, Inc. | 4 | $124 |
Products named: QULIPTA, VALTOCO, Symbravo, VUMERITY, UBRELVY, LYBALVI, AUSTEDO XR, BRIUMVI.
Industry payments across CA — which companies pay providers there.
